| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | 1,7 M € | +1.5% | 1,7 M € | -2.2% | 1,7 M € | -1.1% | 1,7 M € | +9.4% | 1,6 M € | +30.6% | 1,2 M € | ||||||||||||
| Gross margin | 410,9 k € | +19.0% | 345,3 k € | -3.4% | 357,5 k € | -9.9% | 396,7 k € | +11.9% | 354,6 k € | +6.2% | 333,9 k € | +8.9% | 306,6 k € | +16.3% | 263,6 k € | +7.2% | 245,8 k € | +25.7% | 195,6 k € | -55.2% | 436,8 k € | -4.2% | 456,0 k € | +14.6% | 397,8 k € | -3.7% | 412,9 k € | -6.7% | 442,4 k € | +21.2% | 364,9 k € | +162.8% | 138,8 k € | |
| EBITDA | 227,9 k € | +36.5% | 167,0 k € | -12.1% | 190,0 k € | -21.6% | 242,3 k € | +13.3% | 214,0 k € | +11.0% | 192,8 k € | +33.3% | 144,6 k € | +9.5% | 132,1 k € | +10.0% | 120,1 k € | +61.3% | 74,4 k € | +100.6% | 37,1 k € | -77.7% | 166,2 k € | +43.0% | 116,2 k € | -21.5% | 148,0 k € | -7.3% | 159,7 k € | +26.4% | 126,3 k € | +1121.7% | -12,4 k € | |
| Operating profit | 159,5 k € | +60.7% | 99,2 k € | -21.6% | 126,6 k € | -34.8% | 194,0 k € | +29.9% | 149,3 k € | +16.6% | 128,1 k € | +62.7% | 78,7 k € | +192.5% | 26,9 k € | +44.2% | 18,7 k € | +232.8% | -14,0 k € | +21.7% | -18,0 k € | -115.9% | 112,8 k € | +73.9% | 64,8 k € | -11.5% | 73,3 k € | -7.4% | 79,1 k € | +83.2% | 43,2 k € | +143.7% | -98,8 k € | |
| Profit/loss | 115,3 k € | +70.1% | 67,8 k € | -23.5% | 88,6 k € | -41.4% | 151,1 k € | +43.8% | 105,1 k € | +30.4% | 80,6 k € | +46.9% | 54,9 k € | +226.1% | 16,8 k € | +109.2% | 8,0 k € | +126.1% | -30,8 k € | -70.1% | -18,1 k € | -124.4% | 74,4 k € | +78.3% | 41,7 k € | -29.2% | 59,0 k € | -11.0% | 66,2 k € | +193.1% | 22,6 k € | +122.9% | -98,9 k € | |
| Equity | 964,4 k € | +13.6% | 849,1 k € | +8.7% | 781,3 k € | +12.8% | 692,8 k € | +17.1% | 591,6 k € | +21.6% | 486,5 k € | +19.9% | 405,9 k € | -21.3% | 516,0 k € | +3.4% | 499,2 k € | +1.6% | 491,1 k € | -5.9% | 521,9 k € | -3.4% | 540,1 k € | +16.0% | 465,7 k € | +9.8% | 423,9 k € | +16.2% | 365,0 k € | +22.2% | 298,7 k € | +8.2% | 276,1 k € | |
| Total assets | 1,4 M € | +3.6% | 1,4 M € | +5.3% | 1,3 M € | +0.1% | 1,3 M € | +6.4% | 1,2 M € | +9.0% | 1,1 M € | +3.9% | 1,1 M € | -5.7% | 1,1 M € | -1.4% | 1,2 M € | -2.5% | 1,2 M € | +2.8% | 1,2 M € | -7.2% | 1,3 M € | +5.1% | 1,2 M € | -2.3% | 1,2 M € | -4.5% | 1,3 M € | -0.6% | 1,3 M € | +4.6% | 1,2 M € | |
| Cash | 442,4 k € | +44.1% | 307,1 k € | +26.9% | 242,0 k € | -32.8% | 360,3 k € | -4.9% | 378,7 k € | +72.9% | 219,1 k € | +118.1% | 100,5 k € | -40.0% | 167,4 k € | +111.9% | 79,0 k € | -15.7% | 93,8 k € | -76.5% | 399,6 k € | -10.6% | 446,7 k € | +35.3% | 330,2 k € | +22.6% | 269,4 k € | +2.5% | 262,9 k € | +42.7% | 184,2 k € | +251.7% | 52,4 k € | |
| Debts | 458,1 k € | -12.6% | 524,1 k € | +0.3% | 522,5 k € | -14.2% | 609,2 k € | -3.7% | 632,4 k € | -0.7% | 636,6 k € | -5.8% | 675,5 k € | +7.2% | 630,2 k € | -5.0% | 663,2 k € | -5.5% | 701,5 k € | +18.9% | 590,1 k € | -16.7% | 708,1 k € | -2.2% | 724,0 k € | -8.8% | 793,8 k € | -12.2% | 904,4 k € | -8.1% | 984,0 k € | +3.7% | 949,2 k € | |
| Staff | 2,6 | 2,7 | 2,6 | 2,7 | 2,5 | 2,5 | 3 | 2,4 | 2,2 | 2,1 | 6,4 | 6,2 | 6,3 | 6,7 | 6,2 | 5 | 3,6 | |||||||||||||||||
Private limited company · Seneffe · incorporated on 13/12/2007 · 2,6 ETP
Private limited company profitable and well capitalised. Cash position rising (+44.1%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
PHARMA-LOUVE is a Private limited company incorporated in 2007. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Seneffe. It employs on average 2,6 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette